| XTNT |
Xtant Medical Holdings, Inc. |
Common Stock, par value $0.000001 per share |
49% |
$50,543,166 |
|
68,394,000 |
0% |
Nantahala Capital Management, LLC |
01 Aug 2025 |
| EGRX |
Eagle Pharmaceuticals, Inc. |
Common stock, $0.001 par value per share |
38% |
$14,341,106 |
|
4,945,209 |
0% |
Nantahala Capital Management, LLC |
30 Jun 2025 |
| EVOK |
EVOKE PHARMA, INC. |
Common Stock, par value $0.0001 per share |
16% |
$101,856 |
|
254,639 |
|
Nantahala Capital Management, LLC |
03 Feb 2025 |
| AYTU |
AYTU BIOPHARMA, INC |
Common Stock, par value $0.0001 per share |
14% |
$1,423,724 |
|
1,086,812 |
|
Nantahala Capital Management, LLC |
06 Jun 2025 |
| TELA |
TELA Bio, Inc. |
Common Stock, $0.001 par value per share |
13% |
$4,804,893 |
+$1,069,026 |
5,111,588 |
+29% |
Nantahala Capital Management, LLC |
30 Apr 2025 |
| TLPH |
TALPHERA, INC. |
Common Stock, par value $0.001 per share |
12% |
$976,334 |
|
1,992,519 |
|
Nantahala Capital Management, LLC |
31 Mar 2025 |
| ABEO |
ABEONA THERAPEUTICS INC. |
Common Stock, $0.01 par value |
10% |
$27,327,316 |
+$988,597 |
5,184,662 |
+3.8% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| GUTS |
Fractyl Health, Inc. |
Common Stock, $0.00001 par value per share |
10% |
$21,120,969 |
|
13,283,628 |
|
Nantahala Capital Management, LLC |
30 Sep 2025 |
| APYX |
APYX MEDICAL CORPORATION |
Common Stock |
10% |
$14,394,468 |
+$2,168,145 |
4,112,705 |
+18% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| IRD |
Opus Genetics, Inc. |
Common Stock, $0.0001 par value per share |
10% |
$14,318,247 |
+$1,755,146 |
7,123,506 |
+14% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| UNCY |
UNICYCIVE THERAPEUTICS, INC. |
Common Stock, par value $0.001 per share |
10% |
$13,389,705 |
|
2,281,040 |
|
Nantahala Capital Management, LLC |
31 Dec 2025 |
| NSPR |
InspireMD, Inc. |
Common Stock, par value $0.0001 per share |
10% |
$10,256,307 |
+$2,934,884 |
4,255,729 |
+40% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| QNCX |
Quince Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
10% |
$9,156,792 |
+$1,392,249 |
5,620,422 |
+18% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| DRIO |
DarioHealth Corp. |
Common Stock, par value $0.0001 per share |
10% |
$8,098,794 |
+$1,409,189 |
688,673 |
+21% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| OPTN |
OPTINOSE, INC. |
Common stock, par value $0.001 per share |
10% |
$5,904,970 |
|
15,140,948 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| GRCE |
Grace Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
10% |
$5,616,773 |
+$646,500 |
1,586,659 |
+13% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| DRIO |
DarioHealth Corp. |
Common Stock, par value $0.0001 per share |
10% |
$3,376,814 |
+$847,493 |
4,690,019 |
+34% |
Nantahala Capital Management, LLC |
30 Jun 2025 |
| ELUT |
Elutia Inc. |
Class A Common Stock, par value $0.001 per share |
10% |
$2,846,149 |
+$300,693 |
4,124,854 |
+12% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| PHGE |
BiomX Inc. |
Common stock, $0.0001 par value |
10% |
$1,496,518 |
+$420,034 |
2,494,197 |
+39% |
Nantahala Capital Management, LLC |
31 Mar 2025 |
| UNCY |
UNICYCIVE THERAPEUTICS, INC. |
Common Stock, par value $0.001 per share |
10% |
$1,391,993 |
+$466,046 |
1,855,991 |
+50% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| EDSA |
EDESA BIOTECH, INC. |
Common Shares, without par value |
10% |
$1,266,263 |
+$229,541 |
855,583 |
+22% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| KPRX |
KIORA PHARMACEUTICALS, INC. |
Common Stock, $0.01 par value |
10% |
$1,018,394 |
+$160,860 |
363,712 |
+19% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| PHGE |
BiomX Inc. |
Common stock, $0.0001 par value |
10% |
$355,700 |
|
156,696 |
|
Nantahala Capital Management, LLC |
31 Dec 2025 |
| NDLS |
NOODLES & COMPANY |
Class A Common Stock, $0.01 par value per share |
9.9% |
$4,463,246 |
|
4,508,329 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| SSKN |
STRATA SKIN SCIENCES, INC. |
Common Stock, $0.001 Par Value |
9.7% |
$1,034,028 |
|
403,917 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| FOSL |
FOSSIL GROUP, INC. |
Common Stock, par value $0.01 per share |
9.5% |
$8,801,899 |
+$1,554,623 |
5,087,803 |
+21% |
Nantahala Capital Management, LLC |
30 Jun 2025 |
| AVTX |
AVALO THERAPEUTICS, INC. |
Common Stock, $0.001 par value |
9.4% |
$15,696,850 |
+$4,257,850 |
1,235,000 |
+37% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| ASRT |
ASSERTIO HOLDINGS, INC. |
Common Stock, $0.0001 par value |
9.4% |
$5,905,902 |
|
8,948,336 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| FLWS |
1 800 FLOWERS COM INC |
Class A common stock |
9.2% |
$15,493,099 |
+$6,293,099 |
3,368,065 |
+68% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| BVS |
BIOVENTUS INC. |
Class A Common Stock, $0.001 par value per share |
9% |
$46,565,003 |
+$5,902,520 |
6,047,403 |
+15% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| EOLS |
EVOLUS, INC. |
Common Stock, par value $0.00001 per share |
8.8% |
$35,162,902 |
+$12,129,656 |
5,726,857 |
+53% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| RMBL |
RumbleOn, Inc. |
Class B Common Stock, $0.001 par value |
8.7% |
$8,034,327 |
|
3,066,537 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| ANEB |
ANEBULO PHARMACEUTICALS, INC. |
Common Stock |
8.5% |
$3,582,872 |
|
3,547,398 |
0% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| EB |
EVENTBRITE, INC. |
Class A common stock, $0.00001 par value |
8.4% |
$17,215,115 |
+$2,269,129 |
6,831,395 |
+15% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| HLF |
HERBALIFE LTD. |
Common Shares, par value $0.0005 per share |
8.4% |
$130,054,218 |
+$23,362,194 |
8,681,857 |
+22% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| ASPS |
ALTISOURCE PORTFOLIO SOLUTIONS S.A. |
Common Stock, $0.01 par value |
8.4% |
$8,584,660 |
-$12,546,811 |
1,006,408 |
-59% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| DXLG |
DESTINATION XL GROUP, INC. |
Common Stock, $0.01 par value |
8.4% |
$5,901,550 |
|
4,505,000 |
|
Nantahala Capital Management, LLC |
30 Sep 2025 |
| IMUX |
Immunic, Inc. |
Common Stock, $0.0001 par value |
8.2% |
$7,057,316 |
-$174,188 |
10,378,406 |
-2.4% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| SNTI |
Senti Biosciences, Inc. |
Common stock, par value $0.0001 per share |
8.1% |
$7,037,400 |
+$5,422,973 |
2,220,000 |
+336% |
Nantahala Capital Management, LLC |
31 Mar 2025 |
| CRMT |
AMERICA'S CAR-MART, INC. |
Common Stock, par value $0.01 per share |
7.8% |
$31,673,423 |
|
644,686 |
|
Nantahala Capital Management, LLC |
10 Mar 2025 |
| FULC |
FULCRUM THERAPEUTICS, INC. |
Common stock, par value $0.001 per share |
7.7% |
$17,439,379 |
|
4,777,912 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| AVR |
Anteris Technologies Global Corp. |
Common stock, par value $0.0001 per share |
7.5% |
$14,301,351 |
+$5,571,420 |
3,143,154 |
+64% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| RMR |
RMR GROUP INC. |
Class A common stock, $0.001 par value per share |
7.2% |
$18,768,198 |
|
1,147,902 |
|
Nantahala Capital Management, LLC |
30 Jun 2025 |
| HAIN |
THE HAIN CELESTIAL GROUP, INC. |
Common Stock, $0.01 par value |
7.2% |
$7,638,683 |
|
6,528,789 |
|
Nantahala Capital Management, LLC |
31 Dec 2025 |
| STKS |
ONE GROUP HOSPITALITY, INC. |
Common Stock |
6.8% |
$6,262,182 |
+$1,209,963 |
2,087,394 |
+24% |
Nantahala Capital Management, LLC |
31 Dec 2024 |
| KRRO |
Korro Bio, Inc. |
Common Stock, par value $0.001 per share |
6.4% |
$5,394,000 |
|
600,000 |
|
Nantahala Capital Management, LLC |
31 Dec 2025 |
| EHTH |
EHEALTH, INC. |
Common Stock, par value $0.001 per share |
5.8% |
$7,591,811 |
+$1,939,500 |
1,761,441 |
+34% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| CLRB |
Cellectar Biosciences, Inc. |
Common stock, par value $0.00001 |
5.7% |
$727,066 |
-$339,478 |
2,507,125 |
-32% |
Nantahala Capital Management, LLC |
31 Dec 2024 |
| IKT |
INHIBIKASE THERAPEUTICS, INC. |
Common Stock, $0.001 par value |
5.7% |
$14,075,832 |
+$3,478,584 |
7,037,916 |
+33% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| CONNQ |
CONNS, INC. |
Common Stock, par value $0.01 per share |
5.6% |
$41,693 |
-$26,244 |
1,389,773 |
-39% |
Nantahala Capital Management, LLC |
31 Dec 2024 |
| IMAX |
IMAX Corporation |
Common Shares, no par value |
5.3% |
$64,717,646 |
|
2,778,774 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| FOXF |
Fox Factory Holding Corp. |
Common Stock, par value $0.001 per share |
5.2% |
$37,441,813 |
|
2,188,300 |
|
Nantahala Capital Management, LLC |
31 Dec 2025 |
| SRZN |
Surrozen, Inc./DE |
Common Stock, $0.0001 par value per share |
5.2% |
$4,011,184 |
+$1,025,211 |
455,299 |
+34% |
Nantahala Capital Management, LLC |
30 Jun 2025 |
| GOGO |
Gogo Inc. |
Common stock, par value $0.0001 per share |
5.1% |
$31,925,450 |
|
6,792,649 |
|
Nantahala Capital Management, LLC |
31 Dec 2025 |
| DHX |
DHI Group, Inc. |
Common Stock, par value $0.01 per share |
5% |
$3,679,742 |
-$3,997 |
2,374,027 |
-0.11% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| RZLT |
REZOLUTE, INC. |
Common Stock, par value $0.001 per share |
4.9% |
$11,317,609 |
-$8,350,591 |
2,857,982 |
-42% |
Nantahala Capital Management, LLC |
31 Dec 2024 |
| TITN |
TITAN MACHINERY INC. |
Common Stock, $0.00001 par value per share |
4.9% |
$24,096,413 |
-$10,391,943 |
1,135,552 |
-30% |
Nantahala Capital Management, LLC |
30 Jun 2025 |
| VSTM |
Verastem, Inc. |
Common Stock, $0.0001 par value per share |
4.7% |
$29,301,052 |
-$6,413,490 |
3,795,473 |
-18% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| VTGN |
VISTAGEN THERAPEUTICS, INC. |
Common Stock, par value $0.001 per share |
4.7% |
$1,445,253 |
-$912,064 |
1,953,045 |
-39% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| GAIA |
GAIA, INC. |
Class A Common Stock ($0.0001 par value) |
4.6% |
$4,353,582 |
-$1,956 |
914,618 |
-0.04% |
Nantahala Capital Management, LLC |
31 Mar 2025 |
| APRE |
Aprea Therapeutics, Inc. |
Common stock, par value $0.001 per share |
4.5% |
$386,829 |
|
411,520 |
0% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| BKSY |
BLACKSKY TECHNOLOGY INC. |
Class A common stock, par value $0.0001 per share |
4.5% |
$11,663,698 |
-$9,087,802 |
1,377,060 |
-44% |
Nantahala Capital Management, LLC |
31 Dec 2024 |
| BNTC |
BENITEC BIOPHARMA INC. |
Common Stock, par value $0.0001 |
4.4% |
$14,111,462 |
|
1,038,371 |
0% |
Nantahala Capital Management, LLC |
31 Mar 2025 |
| ZVRA |
ZEVRA THERAPEUTICS, INC. |
Common Stock, $0.0001 par value per share |
4.4% |
$16,920,608 |
-$4,220,064 |
2,340,333 |
-20% |
Nantahala Capital Management, LLC |
31 Dec 2024 |
| CDXS |
Codexis, Inc. |
Common Stock, par value $0.0001 per share |
4.3% |
$6,825,958 |
|
2,967,808 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| TLSI |
TRISALUS LIFE SCIENCES, INC. |
Common stock, $0.0001 par value |
4.1% |
$9,487,139 |
+$187,139 |
2,040,245 |
+2% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| RAPT |
RAPT Therapeutics, Inc. |
Common Stock $0.0001 par value per share |
3.8% |
$16,074,692 |
-$8,467,788 |
623,282 |
-35% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| QURE |
uniQure N.V. |
Ordinary Shares, par value EUR 0.05 |
3.8% |
$29,546,669 |
-$13,394,318 |
2,051,852 |
-31% |
Nantahala Capital Management, LLC |
30 Jun 2025 |
| SVRA |
Savara Inc. |
Common Stock, par value $0.001 per share |
3.6% |
$43,481,115 |
-$8,469,105 |
7,344,783 |
-16% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| CMPS |
COMPASS Pathways plc |
American Depositary Shares, each representing one ordinary share, par value of GBP 0.008 per share |
3.6% |
$19,965,125 |
-$14,038,500 |
3,484,315 |
-41% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| NVNO |
enVVeno Medical Corporation |
Common Stock, $0.00001 par value |
3.5% |
$624,180 |
-$540,807 |
688,940 |
-46% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| ESTA |
Establishment Labs Holdings Inc. |
Common Shares, No Par Value |
3.4% |
$65,938,118 |
-$65,812,208 |
987,689 |
-50% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| PTON |
Peloton Interactive, Inc. |
Class A common stock, $0.000025 par value per share |
3.4% |
$81,276,380 |
-$41,769,605 |
12,314,603 |
-34% |
Nantahala Capital Management, LLC |
31 Dec 2024 |
| RDVT |
RED VIOLET, INC. |
Common Stock, $0.001 par value per share |
3.3% |
$17,048,919 |
|
452,466 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| VMD |
Viemed Healthcare, Inc. |
Common Shares, no par value |
2.9% |
$7,889,098 |
|
1,135,122 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| XFOR |
X4 PHARMACEUTICALS, INC |
Common Stock, par value $0.001 per share |
2.8% |
$9,528,431 |
+$798,030 |
2,449,468 |
+9.1% |
Nantahala Capital Management, LLC |
31 Dec 2025 |
| IMAX |
IMAX Corporation |
Common Shares, no par value |
2.7% |
|
|
1,400,351 |
-50% |
Nantahala Capital Management, LLC |
31 Dec 2024 |
| NMTC |
NeuroOne Medical Technologies Corporation |
Common stock, $0.001 par value |
2.6% |
$471,270 |
|
798,762 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| NKTR |
NEKTAR THERAPEUTICS |
Common Stock, $0.0001 par value |
2.2% |
$23,813,902 |
-$16,571,499 |
418,522 |
-41% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| SLNO |
SOLENO THERAPEUTICS INC |
Common Stock, $0.001 par value |
2% |
$86,766,978 |
-$140,918,982 |
1,001,350 |
-62% |
Nantahala Capital Management, LLC |
30 Jun 2025 |
| LXFR |
Luxfer Holdings PLC |
Ordinary Shares, nominal value 0.50 GBP each |
1.6% |
$4,193,314 |
|
413,950 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| LYRA |
Lyra Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
1.1% |
$84,253 |
|
702,106 |
|
Nantahala Capital Management, LLC |
30 Sep 2024 |
| CLRB |
Cellectar Biosciences, Inc. |
Common stock, par value $0.00001 |
0.06% |
$5,412 |
|
1,109 |
|
Nantahala Capital Management, LLC |
30 Jun 2025 |
| THRD |
THIRD HARMONIC BIO, INC. |
Common Stock, par value $0.0001 per share |
0% |
$0 |
-$15,809,618 |
0 |
-100% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| THTX |
Theratechnologies Inc. |
Common Shares |
0% |
$0 |
-$8,599,491 |
0 |
-100% |
Nantahala Capital Management, LLC |
30 Sep 2025 |
| EVOK |
Evoke Pharma Inc |
Common Stock, par value $0.0001 per share |
0% |
$0 |
-$2,899,055 |
0 |
-100% |
Nantahala Capital Management, LLC |
17 Dec 2025 |
| OPTN |
OPTINOSE, INC. |
Common stock, par value $0.001 per share |
0% |
$0 |
-$9,159,805 |
0 |
-100% |
Nantahala Capital Management, LLC |
30 Jun 2025 |